Company: MYGN
Filing Date: 2025-02-28
Form Type: 10-K
Source: 0000899923-25-000019
Chunk: 233

Company: MYRIAD GENETICS INC
Filing Date: 2025-02-28
Form: 10-K
Item: Item 8
Chunk 233
---
 general partner, the Boyer Company, L.C.10-K(Exhibit 10.44)9/24/1998000-26642.2Amendment to Phase II Lease Agreement, dated February 3, 2016, between Myriad Genetics, Inc. and HCPI/UTAH II, LLC10-Q(Exhibit 10.2)5/4/2016000-26642.3Lease Termination Agreement, dated December 18, 2023, between Myriad Genetics, Inc. and HCPI/Utah II, LLC10-K (Exhibit 10.2.3)2/28/2024000-2664210.3.1Lease Agreement, dated March 31, 2001, between the Registrant and Boyer Research Park Associates VI, by its general partner, The Boyer Company, L.C.10-Q(Exhibit 10.1)5/15/2001000-26642.2Amendment to Phase III Lease Agreement, dated February 3, 2016, between Myriad Genetics, Inc. and HCPI/UTAH II, LLC10-Q(Exhibit 10.3)5/4/2016000-26642

108

Table of Contents

ExhibitNumberExhibit DescriptionFiled with thisReportIncorporated byReference hereinfrom Form orScheduleFiling DateSEC File/RegistrationNumber.3Lease Termination Agreement, dated December 18, 2023, between Myriad Genetics, Inc. and HCPI/Utah II, LLC10-K (Exhibit 10.3.3)2/28/2024000-2664210.4.1Lease Agreement, dated February 9, 2022, between Myriad Genetics, Inc. and Bay Bridge/Corporate, LLC10-K (Exhibit 10.4)2/28/2024000-26642.2Amendment to Building D Lease Agreement, dated April 10, 2024, between Myriad Genetics, Inc. and ATP SLC D, LLCX10.5Lease, effective December 7, 2021, between Myriad Women's Health, Inc. and Bayside Area Development, LLC10-K (Exhibit 10.5)2/28/2024000-2664210.6.1Lease Agreement, dated December 1, 2012, by and between Assurex